Capital Advisory Group Advisory Services, LLC Seagen Inc. Transaction History

Capital Advisory Group Advisory Services, LLC

$250 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	BUY	$191.51 - $216.16 $242,260 - $273,442	1,265 New	1,265 $268,000
Q1 2023 Apr 19, 2023	BUY	$127.59 - $203.08 $161,401 - $256,896	1,265 New	1,265 $256,000
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $167,893 - $276,706	-1,543 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$119.61 - $157.85 $7,176 - $9,471	-60 Reduced 3.74%	1,543 $222,000
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $7,556 - $10,115	53 Added 3.42%	1,603 $248,000
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $4,273 - $5,094	30 Added 1.97%	1,550 $263,000
Q2 2021 Nov 12, 2021	BUY	$135.08 - $161.1 $176,414 - $210,396	1,306 Added 610.28%	1,520 $240,000
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $6,462 - $8,967	47 Added 28.14%	214 $30,000
Q4 2020 Feb 18, 2021	BUY	$164.63 - $211.93 $27,493 - $35,392	167 New	167 $29,000

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.

Account